| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC | EVP & General Counsel | Common Stock | 97,271 | $4,547,419 | $46.75 | 10 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COLL | COLLEGIUM PHARMACEUTICAL, INC | 10 Feb 2026 | 3 | -$130,012 | 4 | EVP & General Counsel | 12 Feb 2026, 16:30 |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | 17 Mar 2025 | 1 | $0 | 4 | EVP & General Counsel | 19 Mar 2025, 16:36 |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | 17 Mar 2025 | 0 | $0 | 3 | EVP & General Counsel | 19 Mar 2025, 16:34 |